Stock Price Quote

ANUH PHARMA LTD.

NSE : ANUHPHRBSE : 506260ISIN CODE : INE489G01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE168.60-5.25 (-3.02 %)
PREV CLOSE ( ) 173.85
OPEN PRICE ( ) 174.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 21874
TODAY'S LOW / HIGH ( )167.00 175.50
52 WK LOW / HIGH ( )167 265
NSE168.56-5.49 (-3.15 %)
PREV CLOSE( ) 174.05
OPEN PRICE ( ) 174.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 38536
TODAY'S LOW / HIGH( ) 166.92 175.44
52 WK LOW / HIGH ( )166.92 245.7
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1960
Management Info
Arun Todarwal - Chairman - Managing Director
Registered Office

Address 3 - A, Shivsasgar Estate, North Wing,Dr. Annie Basant Road,Worli,
Mumbai,
Maharashtra-400018

Phone 022-66227575

Email anuh@sk1932.com

Website www.anuhpharma.com

Registrars Details
Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE, NSE

NEWS

04Jan Anuh Pharma informs about credit rating
Pursuant to Regulation 30 Securities and Exchange Board of India (Listin..
03Sep Anuh Pharma informs about disclosure
Anuh Pharma has informed that the exchange has received the disclosure u..
22Aug Anuh Pharma informs about change in di
Anuh Pharma has informed that Sandeep Madhusudan Joshi (DIN: 00516409),..
10Jul Anuh Pharma informs about confirmation
In accordance with Regulation 74 (5) of the SEBI (Depositories and Parti..
24Jun Anuh Pharma informs about closure of t
Anuh Pharma has informed that pursuant to the SEBI (Prohibition of Insid..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit103.44600.570000000001
Gross Profit 132.66 783.090000000001
Operating Profit 157.27872.470000000001
Net Sales 1595.136470.04

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Ajanta Pharma (BSE)
peergroup  2558.40 (2.61%)
M.Cap ( in Cr)31957.51
Coral Laboratories (BSE)
peergroup  807.60 (8.54%)
M.Cap ( in Cr)288.52
Vimta Labs (BSE)
peergroup  1119.70 (3.91%)
M.Cap ( in Cr)2488.29
Mercury Laboratories (BSE)
peergroup  849.00 (3.78%)
M.Cap ( in Cr)101.88
Aarti Drugs (BSE)
peergroup  410.85 (7.20%)
M.Cap ( in Cr)3749.83

Shareholding Pattern

PROMOTERS 69.92%
NON-INSTITUTION 30.06%
FI/BANKS/INSURANCE 0%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Anuh Pharma Ltd.

Anuh Pharma Ltd. was incorporated in the year 1960. Its today's share price is 168.6. Its current market capitalisation stands at Rs 844.89 Cr. In the latest quarter, company has reported Gross Sales of Rs. 6502.84 Cr and Total Income of Rs.6591.02 Cr. The company's management includes Harmanbhai Tulsibhai Patel, Gaurav Shah, Ketan Shah, Samir Shah, Bharat Shah, Siddharth Shah, Pradeep Thakur, Mita Dixit, Vivek Shah, Ritesh Shah, Bipin Shah, Arun Todarwal, Manan Jayesh Vadhan.

It is listed on the BSE with a BSE Code of 506260 , NSE with an NSE Symbol of ANUHPHR and ISIN of INE489G01022. It's Registered office is at 3 - A, Shivsasgar Estate, North Wing,Dr. Annie Basant Road,WorliMumbai-400018, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Jayantilal Thakkar & Co, S I MOGUL & CO., SI Mogul & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.